docs: correct watchlist field descriptions (page-views, not pipeline)

README.md

@@ -201,7 +201,7 @@ print(body[:500])
 - Activity score and tier across indications
 - Deal counts and partnership history
 - **Investment Profile** — public/private status, ticker (exchange + symbol), total capital raised, latest funding round, key investors, and recent pipeline/deal developments sourced from public financial data
-- **Competitive drug watchlist** — organization's pipeline drugs ranked by research attention over the trailing 7-day window
+- **Competitive drug watchlist** — the drugs this organization viewed most over the trailing 7-day window (predominantly other companies' drugs, surfacing competitive interest)
 
 **Target articles** include:
 - Gene symbol, protein family, disease associations
@@ -241,9 +241,9 @@ print(body[:500])
 | `exchange` | company | Stock exchange (e.g. `NYSE`, `NASDAQ`, `KOSDAQ`) |
 | `total_raised` | company | Total disclosed capital raised (private companies) |
 | `latest_round` | company | Most recent disclosed funding round (e.g. `Series B · $215M`) |
-| `watchlist_total_views_7d` | company | Total research activity across the organization's watched pipeline |
-| `watchlist_drug_count` | company | Number of pipeline drugs the organization is actively monitoring |
-| `watchlist_top_drug` | company | Most-viewed drug in the organization's watchlist |
+| `watchlist_total_views_7d` | company | Total page-views the organization generated across all drugs it researched in the trailing 7-day window (predominantly other companies' drugs, not its own pipeline) |
+| `watchlist_drug_count` | company | Number of distinct drugs the organization viewed in the trailing 7-day window |
+| `watchlist_top_drug` | company | The single drug the organization viewed most in the trailing 7-day window |
 | `landscape_total_views_7d` | indication | Total research activity across all drugs in the indication |
 | `landscape_active_orgs_7d` | indication | Number of organizations actively researching the indication |